CLINICAL_TRIALS
trial_result
· 2021-06-11
Clinical Trial Update: Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study. [Phase 4]
Summary
A Phase 4 rollover trial update for everolimus in patients who completed a prior Novartis-sponsored everolimus study; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Neoplasms | Phase 4 | Status: COMPLETED | Results posted: 2021-06-11